Safety study of a vaccine for cocaine dependence
Part of Mental health clinical trials.
This early-stage study tests how safe an experimental “cocaine vaccine” is and how the body reacts to it. You must also be in behavioral therapy, and the study aims to see whether the vaccine can be given safely to people with cocaine use disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and understand study instructions
- You must be HIV-negative (this study excludes HIV infection)
- You are 21 to 69 years old and weigh more than 45 kg
- You have a cocaine use disorder and used cocaine in the last 60 days
- If you could become pregnant or father a child, you must use reliable birth control during the whole study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of ketamine (a medicine that may help the brain change) and neurofeedback training (a brain-exercise technique) can help people with cocaine addiction. The goal is to see if these treatments can improve brain flexibility and reduce cravings.
This trial tests whether a non-invasive brain stimulation technique called high-frequency repetitive transcranial magnetic stimulation (HF rTMS) can help reduce cocaine cravings and change brain chemistry. It may be a good option if you have cocaine use disorder and want to explore a new treatment that doesn't involve medication.
This study looks at how cravings for cocaine change over time in people who have recently stopped using. Researchers will measure brain activity to understand this process better.
This study looks at how your body and mind might get more sensitive to crack-cocaine over time (behavioral sensitization) and what you expect from using it. Your participation helps us better understand addiction patterns.
This early-phase study uses brain imaging to understand how cocaine use disorder affects brain function. It may help researchers learn more about brain pathways involved in craving and treatment targets.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
Hear when a new Cocaine Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.